New Haven, Connecticut 06519


This study is designed to develop an effective psychotherapy for chronic pain and opioid dependence.

Study summary:

This study aims to develop a novel manualized intervention using tailored cognitive-behavioral treatment (CBT) and buprenorphine medication to effectively treat the co-occurring disorders of non-malignant pain and opioid dependence (POD). Specific Aims: 1. To conduct a pre-pilot phase with 16 patients with POD receiving buprenorphine maintenance treatment (BMT). In the pre-pilot phase, we will also explore the effects of different daily buprenorphine dosages on pain and opiate use. 2. To conduct a pilot randomized, clinical trial to obtain data regarding the feasibility, acceptability and efficacy (compared to Physician Management(PM) only) of manual-guided CBT or Educational Counseling (EC) for patients with POD treated with BMT (N=75).


Inclusion Criteria: - 18 years of age or older - prescription opioid addiction criteria - moderate to severe chronic pain - seeking or interested in buprenorphine maintenance - understand English Exclusion Criteria: - methadone maintenance at a dose greater than 40 mg daily - current suicide or homicide risk - life-threatening or unstable medical problem - pregnancy



Primary Contact:

Principal Investigator
Richard S Schottenfeld, MD
Yale University

Declan T Barry, PhD
Phone: 203-285-2708

Backup Contact:

Richard S Schottenfeld, MD
Phone: 203-974-7349

Location Contact:

New Haven, Connecticut 06519
United States

Christopher Cutter, PhD

Site Status: Recruiting

Data Source:

Date Processed: February 04, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.